Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E Ratio 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.09x
EV / EBIT 14.8x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.62
EBIT 1 4.122
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/08/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 918K
-130.99x10.74x-148.61x-.--% 31.07B
16.12x1.28x7.24x5.44% 6.98B
292.56x - - - 4.49B
53.26x9.4x33.01x0.87% 2.86B
29.6x1.19x9.84x0.85% 1.7B
-20.46x - - - 1.82B
33.95x1.48x12.08x1.59% 1.7B
11.78x1.25x4.89x6.42% 1.61B
17.9x7.44x11.97x2.07% 1.53B
Average 33.75x 4.68x -9.94x 2.46% 5.38B
Weighted average by Cap. -44.19x 8.17x -92.92x 1.22%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!